BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32318023)

  • 1. Follicular Output Rate and Follicle-to-Oocyte Index of Low Prognosis Patients According to POSEIDON Criteria: A Retrospective Cohort Study of 32,128 Treatment Cycles.
    Chen L; Wang H; Zhou H; Bai H; Wang T; Shi W; Shi J
    Front Endocrinol (Lausanne); 2020; 11():181. PubMed ID: 32318023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluative effectiveness of follicular output rate, ovarian sensitivity index, and ovarian response prediction index for the ovarian reserve and response of low-prognosis patients according to the POSEIDON criteria: a retrospective study.
    Chen Z; Li W; Ma S; Li Y; Lv L; Huang K; Gong A
    Zygote; 2023 Dec; 31(6):557-569. PubMed ID: 37737063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
    Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.
    Liu X; Xu J; Bi L; Liu P; Jiao X
    Front Endocrinol (Lausanne); 2021; 12():790160. PubMed ID: 34925245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
    Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
    Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
    Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM
    Front Endocrinol (Lausanne); 2021; 12():630550. PubMed ID: 33790862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis.
    Yang R; Zhang C; Chen L; Wang Y; Li R; Liu P; Qiao J
    Reprod Biomed Online; 2020 Nov; 41(5):834-844. PubMed ID: 32978073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors for Live Birth in Fresh
    Li F; Ye T; Kong H; Li J; Hu L; Jin H; Guo Y; Li G
    Front Endocrinol (Lausanne); 2021; 12():630832. PubMed ID: 33967954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Second Follicular Wave Phenomenon in Natural Cycle Assisted Reproduction: A Key Option for Poor Responders through Luteal Phase Oocyte Retrieval.
    Sfakianoudis K; Simopoulou M; Maziotis E; Giannelou P; Tsioulou P; Rapani A; Pantou A; Petroutsou K; Angeli I; Deligeoroglou E; Koutsilieris M; Pantos K
    Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30875815
    [No Abstract]   [Full Text] [Related]  

  • 12. Change in oocyte yield in repeated in vitro fertilization cycles: effect of ovarian reserve.
    Eppsteiner EE; Sparks AE; Liu D; Van Voorhis BJ
    Fertil Steril; 2014 Feb; 101(2):399-402. PubMed ID: 24331835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles.
    Shi W; Zhou H; Tian L; Zhao Z; Zhang W; Shi J
    Front Endocrinol (Lausanne); 2019; 10():409. PubMed ID: 31293519
    [No Abstract]   [Full Text] [Related]  

  • 14. Management Strategies for POSEIDON Group 2.
    Sunkara SK; Ramaraju GA; Kamath MS
    Front Endocrinol (Lausanne); 2020; 11():105. PubMed ID: 32174892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of progestin-primed ovarian stimulation (PPOS) versus minimal stimulation in women of advanced maternal age with poor ovarian response under the Patient-Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) criteria.
    Zhao S; Wang C
    Ann Palliat Med; 2023 Jan; 12(1):133-140. PubMed ID: 36747387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria.
    Lee HJ; Noh HK; Joo JK
    Sci Rep; 2022 Oct; 12(1):17723. PubMed ID: 36271137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.
    Xu Y; Nisenblat V; Lu C; Li R; Qiao J; Zhen X; Wang S
    Reprod Biol Endocrinol; 2018 Mar; 16(1):29. PubMed ID: 29587861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of ovarian follicular dominance during stimulation for IVM impacts usable blastocyst yield.
    Romero S; Pella R; Escudero F; Pérez Y; García M; Orihuela P
    JBRA Assist Reprod; 2018 Mar; 22(1):56-60. PubMed ID: 29338139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.